Bladder cancer: Pelvic lymphadenectomy revisited Journal Article
| Author: | Herr, H. W. |
| Article Title: | Bladder cancer: Pelvic lymphadenectomy revisited |
| Abstract: | The value of pelvic lymphadenectomy in patients undergoing cystectomy for bladder cancer is controversial. While perhaps 1–2 percent of all patients may be cured after excision of positive nodes, the overall contribution of this procedure to survival is minimal. Pelvic lymphadenectomy is however becoming more valuable for staging and therapy in combination with more effective systemic chemotherapy and its role in the overall management of patients with invasive bladder cancer is presently being redefined. Copyright © 1988 Wiley‐Liss, Inc., A Wiley Company |
| Keywords: | survival; major clinical study; cisplatin; doxorubicin; methotrexate; methodology; lymph node metastasis; lymphadenectomy; metastasis; vincristine; bladder cancer; cystectomy; human |
| Journal Title: | Journal of Surgical Oncology |
| Volume: | 37 |
| Issue: | 4 |
| ISSN: | 0022-4790 |
| Publisher: | Wiley Blackwell |
| Date Published: | 1988-04-01 |
| Start Page: | 242 |
| End Page: | 245 |
| Language: | English |
| DOI: | 10.1002/jso.2930370407 |
| PUBMED: | 3361916 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Article -- Export Date: 6 August 2020 -- Source: Scopus |
